CSA Medical, Inc. Appoints Marc Davidson Chief Technology Officer
Published: Apr 09, 2012
BALTIMORE--(BUSINESS WIRE)--CSA Medical, Inc. (www.CSAmedical.com), the leading developer of novel spray cryotherapy devices that flash freeze and ablate diseased tissue inside the body, has appointed Marc Davidson as Chief Technology Officer. Davidson brings to the company more than 25 years of engineering and R&D experience, including more than 15 years leading these functions in the medical device industry. In his new role, Davidson will lead ongoing development and advancement of the company’s patented spray cryotherapy technology platform and therapeutic accessories.